Do you want to read an article? Please log in or register.
Real-world outcomes of ranibizumab biosimilars in various retinal diseases: a Korean multi-center experience-ROSE Korea Study
Retinal Diseases
Related content
Macular Diseases
Treatment Regimens with Ranibizumab in Neovascular Age-Related Macular Degeneration: Real-World Results from the PACIFIC Study
Clin Ophthalmol
Lorenz K, Haritoglou C, Barthelmes D, Sefat AMM, Berk H, Beeke E, Scheffler M, Iwersen M, Müller B, Ziemssen F, members of the PACIFIC study group
doi: 10.2147/OPTH.S512630
Retinal Diseases
Effectiveness and Safety of Biosimilar Anti-Vascular Endothelial Growth Factor for Retinal Diseases: A Systematic Review and Meta-Analysis
Retina
Pandya BU, Mihalache A, Huang RS, Jhaveri A, Cao X, Ballios B, Felfeli T
doi: 10.1097/IAE.0000000000004807
Macular Diseases
Twelve-Month Outcomes of Anti-VEGF Therapy for nAMD with Brolucizumab, Aflibercept, and Ranibizumab in the Polish National Registry: A Multicenter Database Study
J Clin Med
Teper S, Ledwoń D, Romaniszyn-Kania P, Sendecki A, Tuszy A, Nycz J, Mitas AW, Figurska M, Wylęgała E, Rękas M
doi: 10.3390/jcm14196771
Macular Diseases
Real-World 5-Year Outcomes of Age-Related Macular Degeneration with Bevacizumab as First-Line Anti-VEGF
Ophthalmol Ther
Mhmud H, Vermeulen JP, Tigchelaar-Besling OAM, Verbraak FD, Barthelmes D, Gillies M, Ponsioen TL, Klaver CCW
doi: 10.1007/s40123-025-01178-z
Macular Diseases
One-Year Real-World Outcomes of Switching to Aflibercept 8 mg in Eyes with Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report
Ophthalmol Ther
Kitay AM, Tillmann A, Pfister I, Schild C, Bonanata M, Heck K, Spitznagel T, Gabathuler F, Bartolomeo N, Magnin S, Löliger J, Munk MR, Menghini M, Hatz K, Somfai GM, Zweifel S, Ambresin A, Eandi CM, Feltgen N, Weinberger A, Garweg JG, Kurz-Levin MM
doi: 10.1007/s40123-026-01344-x
COMMENTED
Retinal Diseases
Trends in the Incidence of Retinal Artery and Vein Occlusion Before and After COVID-19: A National Study in South Korea (2017-2022)
★ 2
Recommended and commented by
Prof. emer. Dr Josef Flammer, Faculty Member
Am J Ophthalmol
Cho J, Lee NK, Kim JY, Lee CS, Byeon SH, Kim SS, Lee SW, Kim YJ
doi: 10.1016/j.ajo.2025.03.005
COMMENTED
Glaucoma and Ocular PressureRetinal Diseases
Retinal Vessel Traits and Age-Related Eye Disease in the Canadian Longitudinal Study on Aging
★ 2
Recommended and commented by
Prof. emer. Dr Josef Flammer, Faculty Member
Clin Exp Ophthalmol
O'Neil A, Welikala RA, Barman S, Owen CG, Rudnicka AR, Rakesh M, Roy-Gagnon MH, Maberley D, Freeman EE
doi: 10.1111/ceo.14566
Macular Diseases
First-year real-world outcomes of faricimab in clinically significant diabetic macular oedema: a Swiss retina research network report
BMJ Open Ophthalmol
Saad A, Plasencia C, Garweg J, Pfister IB, Munk MR, Eandi CM, Zweifel SA, Grimaldi G, Bartolomeo N, Stillenmunkes R, Schild C, Cattaneo J, Gabathuler F, Menghini M, Ambersin A, Froehlich J, Artemiev D, Weinberger A, Mohamed H, Somfai GM, Hatz K
doi: 10.1136/bmjophth-2025-002467
Macular Diseases
One-Year Real-World Outcomes of Aflibercept 8 mg in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report
Ophthalmol Ther
Grimaldi G, Bartolomeo N, Garweg JG, Pfister IB, Schild C, Peyla A, Tillmann A, De Oliveira Figueiredo EC, Spitznagel T, Kitay AM, Gabathuler F, Zweifel S, Kurz-Levin MM, Ebneter A, Somfai GM, Eandi CM, Munk MR, Ambresin A, Menghini M
doi: 10.1007/s40123-025-01305-w